The alveolar surfactant system, it's pathogenetic significance in acute lung failure (ARDS) and therapeutic perspectives;Das alveolare surfactantsystem, seine pathogenetische bedeutung fur das akute lungenversagen (ARDS) und therapeutische perspektiven

Intensivmedizin und Notfallmedizin

Volumn 37, Issue 4, 2000, Pages 307-317

  Walmrath, D ^a   Gunther A ^a   Grimminger, F ^a   Seeger, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Adult respiratory distress syndrome (ARDS); Alveolar surfactant; Hyaline membranes; Surfactant apoproteins surfactant inhibition; Surfactant phospholipids

Indexed keywords

LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ATELECTASIS; HUMAN; LUNG ALVEOLUS; LUNG ARTERIOVENOUS SHUNT; LUNG COMPLIANCE; LUNG INSUFFICIENCY; LUNG VENTILATION PERFUSION RATIO; PATHOGENESIS; RESPIRATORY FAILURE; REVIEW;

EID: 0343526829     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050340     Document Type: Review

References (66)

1. Akino T (1992) Lipid components of the surfactant system. In: Pulmonary Surfactant (Robertson B, van Golde LMG, Batenburg JJ, eds), pp 19-32, Elsevier Science Publishers Amsterdam
2. Albert RK, Lakshminarayan S, Hildebrandt J, Kirk W (1979) Increased surface tension favours pulmonary edema formation in anaesthetized dogs' lungs. J Clin Invest 63:1015-1018
3. Bachofen M, Weibel EF (1982) Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3:35-56
4. Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B (1986) Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 30:321-328
5. Berry D, Ikegami M, Jobe A (1986) Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 61(5):1741-1748
6. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman H (1990) Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890-897
7. Bredenberg CE, Paskanik AM, Nieman GF (1983) High surface tension pulmonary edema. J Surg Res 34:515-523
8. Burkhardt A (1989) Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 140:513-524
9. Chapman HA, Reilly JJ, Kobzik L (1988) Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages. Am Rev Respir Dis 137:412-419
10. Christner P, Fein A, Goldberg S, Lippmann M, Abrams W, Weinbaum G (1985) Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 131:690-695
11. Cockshutt AM, Weitz J, Possmayer F (1990) Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29(36):8424-8429
12. Collaborative European Multicenter Study Group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics 82:683-691
13. 99mTc-DTPA: effects of surfactant depletion by lung lavage. J Appl Physiol 62(4):1611-1614
14. Fuchimukai T, Fuchiwara T, Takahashi A, Enhorning G (1987) Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62(2):429-437
15. Goerke J, Clements JA (1986) Alveolar surface tension and lung surfactant. In: Handbook of physiology (Macklem PT, Mead J, eds.), pp 247-261 American Physiological Society, Bethesda
16. Gregory TJ, Gadek JE, Weilnad JE, Hyers TM, Crim C, Hudson LD, Steinberg KP, Maunder RA, Spragg RG, Smith RM, Tierney DF, Gipe B, Longmore WJ, Moxley MA (1994) Survanta supplementation in patients with acute respiratory distress syndrome (ARDS). Abstract, Am J Respir Crit Care Med 149:A567
17. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Hudson LD, Maunder RJ, Crim C, Hyers TM (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88:1976-1981
18. Gross NJ, Bublys V, D'Anza J, Brown C (1995) The role of a1-antitrypsin in the control of extracellular surfactant metabolism. Am J Physiol 268:L438-L445
19. Gross NJ, Schultz RM (1992) Requirements for extracellular metabolism of pulmonary surfactant: tentative identification of serine protease. Am J Physiol 262:L446-L453
20. Günther A, Bleyl H, Seeger W (1993) Apoprotein-based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro. Am J Physiol 265:L186-L192
21. Günther A, Kalinowski M, Elssner A, Seeger W (1994) Clot-embedded natural surfactant: kinetics of fibrinolysis and surface activity. Am J Physiol 267: L618-L624
22. Günther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbrück B, Seeger W (2000) Alveolar fibrin formation due to enhanced procoagulant and antifibrinolytic capacities in severe pneumonia - comparison to ARDS. Am J Respir Crit Care Med 161:454-462
23. Günther AG, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W (1996) Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153:176-184
24. Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH (1992) Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 145:24-30
25. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck, L (1982) Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 70:673-683
26. Hasleton PS (1983) Adult respiratory distress syndrome: a review. Histopathology 7:037-332
27. Hawgood S (1989) Pulmonary surfactant apoproteins: a review of protein and genomic structure. Am J Physiol 257 (Lung Cell Mol Physiol 1):L13-L22
28. Holm BA, Notter RH (1987) Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 63(4):1434-1442
29. A/Q abnormalities in hyperoxic lung injury. Am Rev Respir Dis 145:A609
30. Idell S, Gonzalez KK, Bradford H, MacArthur CK, Fein AM, Maunder RJ, Garcia JGN, Griffith DE, Weiland J, Martin TR, McLarty J, Fair DS, Walsh PN, Colman RW (1987) Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Am Rev Respir Dis 136: 1466-1474
31. Ikegami M, Jobe AH, Tabor BL, Rider ED, Lewis JF (1992) Lung albumin recovery in surfactant-treated preterm ventilated lambs. Am Rev Respir Dis 145:1005-1008
32. Iwaarden JF van, Shimizu H, van Golde PHM, Voelker DR, van Golde LMG (1992) Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages. Biochem J 286:5-8
33. Iwaarden JF van, Welmers B, Verhoef J, Haagsman HP, Golde van LMG (1990) Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 2:91-98
34. Jefferies AL, Coates G, O'Brodovich H (1984) Pulmonary epithelial permeability in hyaline-membrane disease. N Engl J Med 311:1075-1080
35. Kaneko T, Sato T, Katsuya H, Miyauchi Y (1990) Surfactant therapy for pulmonary edema due to intratracheally injected bile acid. Crit Care Med 18:77-83
36. Kobayashi T, Ganzuka M, Taniguchi J, Nitta K, Murakami S (1990) Lung lavage and surfactant replacement for hydrochloric acid aspiration in rabbits. Acta Anaesthesiol Scand 34:216-221
37. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B (1991) Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatric Research 29(4):353-356
38. Kuroki Y, Mason R, Voelker D (1988) Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 263(7):3388-3394
39. Lamm WJE, Albert RK (1990) Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am Rev Respir Dis 142:1279-1283
40. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel, Weinbaum G (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304:192-196
41. Lewis JF, Ikegami M, Higuchi R, Jobe A, Absolom D (1991) Nebulized vs. instilled exogenous surfactant in an adult injury model. J Appl Physiol 71(4): 1270-1276
42. Lewis JF, Ikegami M, Jobe AH (1992) Metabolism of exogenously administered surfactant in the acutely injured lungs of adult rabbits. Am Rev Respir Dis 145:19-23
43. Nakstad B, Lydberg T, Skjonsberg OH, Boye NP (1990) Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res 57:827-838
44. Nakstadt B, Boye NP, Lydberg T (1987) Procoagulant activities in human alveolar macrophages. Eur J Respir Dis 71: 459-471
45. Nieman GF, Bredenberg CE (1985) High surface tension pulmonary edema induced by detergent aerosol. J Appl Physiol 58(1):129-136
46. Nieman GF, Goyette D, Paskanik A, Brendenberg C (1990) Surfactant displacement by plasma lavage results in pulmonary edema. Surgery 107:677-683
47. Petty TL, Silvers GW, Paul GW, Stanford RE (1979) Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 75(5):571-576
48. Petty TL, Silvers GW, Paul GW, Stanford RE (1979) Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 75(5):571-578
49. Pison U, Seeger W, Buchhom R, Joka T, Brand M, Obertacke U, Neuhof H, Schmit-Neuerburg KP (1989) Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 140:1033-1039
50. Possmayer F (1988) A proposed nomenclature for pulmonary surfactant-associated proteins. Am Rev Respir Dis 138:990-996
51. Revak SD, Merritt TA, Degryse E, Stefani L, Courtney M, Hallman M, Cochrane CG (1988) Use of human surfactant low molecular apoproteins in the reconstitution of surfactant biologic activity. J Clin Invest 81:826-833
52. Robertson B, Lachmann B (1988) Experimental evaluation of surfactants for replacement therapy. Exp Lung Res 14:279-310
53. Seeger W, Elssner A, Günther A, Kraemer H-J, Kalinowski HO (1993) Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. Am J Respir Cell Mol Biol 9: 213-220
54. Seeger W, Günther A, Thede C (1992) Differential sensitivity to fibrinogen-inhibition of SP-C versus SP-B based surfactants. Am J Physiol (Lung Cell Mol Physiol 5):L286-L291
55. Seeger W, Hübel J, Klapettek K, Pison U, Obertacke U, Joka T, Roka L (1991) Procoagulant activity in bronchoalveolar lavage of severly traumatized patients -relation to the development of acute respiratory distress. Throm Res 61:53-64
56. Seeger W, Stöhr G, Wolf HRD, Neuhof H (1985) Alteration of Surfactant function due to protein leakage: Special interaction with fibrin monomer. J Appl Physiol 58(2):326-338
57. Seeger W, Thede C, Günther A, Grube C (1991) Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro - comparison to natural surfactant. Biochim Biophys Acta 1081: 45-52
58. Strohmaier W, Redl H, Schlag G (1990) Studies of the potential role of a semi-synthetic surfactant preparation in an experimental aspiration trauma in rabbits. Exp Lung Res 16:101-110
59. Tenner AJ, Robinson SL, Borchelt J, Wright JR (1989) Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem 264(23):13923-13928
60. Tierney DF, Johnson RP (1965) Altered surface tension of lung extracts and lung mechanics. J Appl Physiol 20(6):1253-1260
61. van Daal GJ, So KL, Gommers D, Eijking EP, Fivez RB, Sprenger MJ, van Dam DW, Lachman B (1991) Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg 72:589-595
62. Walmrath D, Günther A, Ghofrani AG, Schermuly R, Schneider T, Grimminger F, Seeger W (1996) Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med:154:57-62
63. Whitsett JA, Baatz JE (1992) Hydrophobie surfactant proteins SP-B and SP-C: molecular biology, structure and function. In: Pulmonary Surfactant (Robertson B, van Golde LMG, Batenburg JJ, eds), pp 33-54, Elsevier Science Publishers Amsterdam
64. Wissel H, Looman AC, Fritzsche I, Rüstow B, Stevens PA (1996) SP-A-binding protein BP55 is involved in surfactant endocytosis by type II pneumocytes. Am J Appl Physiol 271:L432-L440
65. Yu SH, Possmayer F (1988) Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purifled from bovine pulmonary surfactant. Biochim Biophys Acta 961:337-350
66. Zelter M, Escudies BJ, Hoeffel JM, Murray JF (1990) Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis 141:1014-1019